STRONGBRIDGE BIOPHARMA plc Revenue
STRONGBRIDGE BIOPHARMA plc reported Revenue of $4.51 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-02-27
- STRONGBRIDGE BIOPHARMA plc revenues for the quarter ending 2018-12-31 was $4.51M, a 51.27% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc revenues for the quarter ending 2018-09-30 was $5.35M, a 111.09% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc revenues for the quarter ending 2018-06-30 was $4.30M, a 180.97% increase year-over-year.
- STRONGBRIDGE BIOPHARMA plc revenues for the quarter ending 2018-03-31 was $3.87M.
- STRONGBRIDGE BIOPHARMA plc revenues for fiscal 2018 was $18.03M, a 155.85% increase from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc revenues for fiscal 2017 was $7.05M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $4.51M 10-K · filed 2019-02-27 | $9.86M derived: sum of 2 quarters · filed 2019-02-27 | $14.16M derived: sum of 3 quarters · filed 2019-02-27 | $18.03M 10-K · filed 2019-02-27 |
| 2018-09-30 | $5.35M 10-K · filed 2019-02-27 | $9.64M derived: sum of 2 quarters · filed 2019-02-27 | $13.51M 10-Q · filed 2018-10-31 | $16.50M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-06-30 | $4.30M 10-K · filed 2019-02-27 | $8.17M 10-Q · filed 2018-08-08 | $11.15M derived: sum of 3 quarters · filed 2019-02-27 | $13.68M derived: sum of 4 quarters · filed 2019-02-27 |
| 2018-03-31 | $3.87M 10-K · filed 2019-02-27 | $6.85M derived: sum of 2 quarters · filed 2019-02-27 | $9.39M derived: sum of 3 quarters · filed 2019-02-27 | $10.92M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-12-31 | $2.98M 10-K · filed 2019-02-27 | $5.52M derived: sum of 2 quarters · filed 2019-02-27 | $7.05M derived: sum of 3 quarters · filed 2019-02-27 | $7.05M 10-K · filed 2019-02-27 |
| 2017-09-30 | $2.53M 10-K · filed 2019-02-27 | $4.06M derived: sum of 2 quarters · filed 2019-02-27 | $4.06M 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $1.53M 10-K · filed 2019-02-27 | $1.53M 10-Q · filed 2018-08-08 |